This one's for Jimmy, I know she is reading.

"DUBLIN----Research and Markets has announced the addition of the "The 2009-2014 Outlook for Acetaminophen and Acetaminophen Combinations in the United States" report to their offering."

My mother-in-law said she heard this on the radio.

"ALEXANDRIA, Va., July 28 -- Oxford Finance Corporation, a subsidiary of Sumitomo Corporation, today ..."

she wants to know what you think.

Oxford Finance Corporation, a subsidiary of Sumitomo Corporation, today announced that it was the lead lender for a $30 million credit facility provided to Cadence Pharmaceuticals. ? Silicon Valley Bank and GE Financial Services, Inc. also participated in the loan agreement.

Sherry Wrote: Take a look at this article

"SAN MATEO, Calif., July 27 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today important progress in the implementation of its reimbursement strategy for Qutenza? (capsaicin) 8% patch. Qutenza is currently available in the United States for the management of neuropathic ..."

I found this posted at BIZ.YAHOO.COM on Wednesday.

"WHITEHOUSE STATION, N.J.----Merck today announced a non-exclusive license agreement with Laboratory Corporation of America? Holdings for the commercialization of a genetic test that may help predict the response of patients with Hepatitis C virus infection to peginterferon alpha-based therapy."